GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hindustan Bio Sciences Ltd (BOM:532041) » Definitions » Price-to-Owner-Earnings

Hindustan Bio Sciences (BOM:532041) Price-to-Owner-Earnings : (As of May. 26, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Hindustan Bio Sciences Price-to-Owner-Earnings?

As of today (2024-05-26), Hindustan Bio Sciences's share price is ₹8.55. Hindustan Bio Sciences does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Hindustan Bio Sciences's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Hindustan Bio Sciences was 7.09. The lowest was 1.35. And the median was 3.12.


BOM:532041's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 27.13
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-26), Hindustan Bio Sciences's share price is ₹8.55. Hindustan Bio Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.14. Therefore, Hindustan Bio Sciences's PE Ratio for today is 61.07.

As of today (2024-05-26), Hindustan Bio Sciences's share price is ₹8.55. Hindustan Bio Sciences's EPS without NRI for the trailing twelve months (TTM) ended in was ₹0.14. Therefore, Hindustan Bio Sciences's PE Ratio without NRI for today is 61.51.

During the past 13 years, Hindustan Bio Sciences's highest PE Ratio without NRI was 130.00. The lowest was 3.21. And the median was 33.15.


Hindustan Bio Sciences Price-to-Owner-Earnings Historical Data

The historical data trend for Hindustan Bio Sciences's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hindustan Bio Sciences Price-to-Owner-Earnings Chart

Hindustan Bio Sciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.85 4.30 - -

Hindustan Bio Sciences Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Hindustan Bio Sciences's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Hindustan Bio Sciences's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hindustan Bio Sciences's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hindustan Bio Sciences's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Hindustan Bio Sciences's Price-to-Owner-Earnings falls into.



Hindustan Bio Sciences Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Hindustan Bio Sciences's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=8.55/-0.06
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hindustan Bio Sciences  (BOM:532041) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Hindustan Bio Sciences Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Hindustan Bio Sciences's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Hindustan Bio Sciences (BOM:532041) Business Description

Traded in Other Exchanges
N/A
Address
Road No. 2, Banjara Hills, H.No. 8-2-269/S, Plot No. 31, Sagar Co-Operative Housing Society, Hyderabad, TG, IND, 500034
Hindustan Bio Sciences Ltd is an India-based company operating in the pharmaceutical and biotechnology sector. It is engaged in the trading of Drugs and Medicines. The company markets a nephrology product, Recombinant Human Erythropoietin, which is useful for the treatment of anemia associated with chronic renal failure. In addition, the firm also manufactures and markets pharmaceutical products in different forms such as tablets, capsules, drops, externals, and syrups. Its other formulations comprise Pantorest, Maxion, Edinil, Aromycin, Livohin and others. Geographically, the group sells its products within India and also exports it to other countries.

Hindustan Bio Sciences (BOM:532041) Headlines

No Headlines